Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002547181 | SCV001092070 | likely benign | Rubinstein-Taybi syndrome | 2023-01-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502898 | SCV002798794 | likely benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2022-01-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925858 | SCV004745777 | likely benign | CREBBP-related disorder | 2021-11-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |